Forecasting The Future: 19 Analyst Projections For Biogen
Forecasting The Future: 19 Analyst Projections For Biogen
预测未来：19位分析师对渤健公司的预测
Throughout the last three months, 19 analysts have evaluated Biogen (NASDAQ:BIIB), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中，19位分析师已经评估了Biogen（纳斯达克：BIIB），提供了从看好到看淡的不同观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $274.32, a high estimate of $342.00, and a low estimate of $200.00. This current average has decreased by 2.86% from the previous average price target of $282.39.
分析师分析的12个月价格目标提供了一些见解，其中平均目标为274.32美元，最高估值为342.00美元，最低估值为200.00美元。这个当前的均值比之前的平均价格目标282.39美元下降了2.86%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
The standing of Biogen among financial experts is revealed through an in-depth...
通过对近期分析师行动的深入...
登录免费看全文
登录/注册